Department of Medicine and Life Sciences, Immunology Unit, Universitat Pompeu Fabra, Barcelona, Spain.
Bioinformatics unit, Centro Nacional de Análisis Genómico, Centre for Genomic Regulation, Barcelona Institute for Science and Technology, Barcelona, Spain.
Blood Adv. 2024 Nov 12;8(21):5510-5526. doi: 10.1182/bloodadvances.2023011306.
Hematopoietic stem cells (HSCs) readily recover from acute stress, but persistent stress can reduce their viability and long-term potential. Here, we show that the nuclear factor of activated T cells 5 (NFAT5), a transcription modulator of inflammatory responses, protects the HSC pool under stress. NFAT5 restrains HSC differentiation to multipotent progenitors after bone marrow transplantation and bone marrow ablation with ionizing radiation or chemotherapy. Correspondingly, NFAT5-deficient HSCs fail to support long-term reconstitution of hematopoietic progenitors and mature blood cells after serial transplant. Evidence from competitive transplant assays shows that these defects are HSC intrinsic. NFAT5-deficient HSCs exhibit enhanced expression of type 1 interferon (IFN-1) response genes after transplant, and suppressing IFN-1 receptor prevents their exacerbated differentiation and cell death after reconstitution and improves long-term regeneration potential. Blockade of IFN-1 receptor also prevented the overdifferentiation of NFAT5-deficient HSCs after bone marrow ablation. These findings show that long-term IFN-1 responses to different hematopoietic stressors drive HSCs toward more differentiated progenitors, and that NFAT5 has an HSC-intrinsic role, limiting IFN-1 responses to preserve reconstitution potential. Our identification of cell-intrinsic mechanisms that strengthen the resistance of HSCs to stress could help to devise approaches to protect long-term stemness during the treatment of hematopoietic malignancies.
造血干细胞(HSCs)能轻易从急性应激中恢复,但持续的应激会降低它们的活力和长期潜能。在这里,我们发现激活 T 细胞的核因子 5(NFAT5)是炎症反应的转录调节剂,可在应激下保护 HSC 池。NFAT5 抑制骨髓移植和电离辐射或化疗后骨髓消融后 HSC 向多能祖细胞的分化。相应地,NFAT5 缺陷的 HSCs 在连续移植后无法支持造血祖细胞和成熟血细胞的长期重建。来自竞争移植实验的证据表明,这些缺陷是 HSC 内在的。移植后,NFAT5 缺陷的 HSCs 表现出 1 型干扰素(IFN-1)反应基因的表达增强,抑制 IFN-1 受体可防止其在重建后过度分化和细胞死亡,并改善长期再生潜能。IFN-1 受体的阻断也阻止了 NFAT5 缺陷的 HSCs 在骨髓消融后的过度分化。这些发现表明,对不同造血应激源的长期 IFN-1 反应促使 HSCs 向更分化的祖细胞发展,而 NFAT5 具有 HSC 内在的作用,限制 IFN-1 反应以维持重建潜能。我们鉴定出细胞内在的机制,增强了 HSCs 对应激的抵抗力,这可能有助于在治疗造血恶性肿瘤时设计保护长期干细胞特性的方法。